The table below summarizes the most recent ACRX insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why ACRX insider buys are important for investors to follow.

Date	Insider	Price	Amount
12-13-2023 Insider Buy	Vincent J. Angotti Chief Executive Officer	$0.73 CAGR »	$7,268.00 10,000 shares
9-11-2023 Insider Buy	Vincent J. Angotti Chief Executive Officer	$0.80 CAGR »	$7,950.00 10,000 shares
6-7-2022 Insider Buy	Vincent J. Angotti Chief Executive Officer	$0.22 CAGR »	$10,333.28 46,400 shares
6-15-2020 Insider Buy	Adrian Adams Director	$1.29 CAGR »	$128,900.00 100,000 shares
6-15-2020 Insider Buy	Vincent J. Angotti Chief Executive Officer	$1.33 CAGR »	$10,035.25 7,547 shares
8-26-2019 Insider Buy	Mark G. Edwards Director	$2.19 CAGR »	$32,805.50 15,000 shares
6-5-2019 Insider Buy	Vincent J. Angotti Chief Executive Officer	$2.31 CAGR »	$11,550.00 5,000 shares
3-12-2019 Insider Buy	Mark G. Edwards Director	$2.99 CAGR »	$56,889.80 19,000 shares
12-14-2018 Insider Buy	Raffi Asadorian Chief Financial Officer	$2.78 CAGR »	$13,883.00 5,000 shares
12-14-2018 Insider Buy	Vincent J. Angotti Chief Executive Officer	$2.78 CAGR »	$10,023.53 3,610 shares
12-12-2018 Insider Buy	Vincent J. Angotti Chief Executive Officer	$2.99 CAGR »	$29,890.00 10,000 shares
11-19-2018 Insider Buy	Pamela P. Palmer Chief Medical Officer	$3.07 CAGR »	$49,120.00 16,000 shares
11-15-2018 Insider Buy	Mark G. Edwards Director	$2.82 CAGR »	$58,376.07 20,700 shares
11-13-2018 Insider Buy	Raffi Asadorian Chief Financial Officer	$3.13 CAGR »	$15,646.00 5,000 shares
8-7-2018 Insider Buy	Mark G. Edwards Director	$2.84 CAGR »	$15,062.60 5,300 shares
8-7-2018 Insider Buy	Vincent J. Angotti Chief Executive Officer	$2.90 CAGR »	$28,950.00 10,000 shares
8-6-2018 Insider Buy	Raffi Asadorian Chief Financial Officer	$2.75 CAGR »	$13,725.00 5,000 shares
8-6-2018 Insider Buy	Pamela P. Palmer Chief Medical Officer	$2.75 CAGR »	$101,750.00 37,000 shares
5-25-2018 Insider Buy	Raffi Asadorian Chief Financial Officer	$3.18 CAGR »	$15,922.50 5,000 shares
11-14-2017 Insider Buy	Mark G. Edwards Director	$1.90 CAGR »	$56,970.00 30,000 shares
11-13-2017 Insider Buy	Raffi Asadorian Chief Financial Officer	$1.94 CAGR »	$9,710.50 5,000 shares
9-11-2017 Insider Buy	Raffi Asadorian Chief Financial Officer	$3.24 CAGR »	$22,705.20 7,000 shares
8-24-2017 Insider Buy	Vincent J. Angotti Chief Executive Officer	$3.00 CAGR »	$45,000.00 15,000 shares
8-24-2017 Insider Buy	Mark G. Edwards Director	$3.02 CAGR »	$15,100.00 5,000 shares
8-22-2017 Insider Buy	Pamela P. Palmer Chief Medical Officer	$2.95 CAGR »	$29,487.00 10,000 shares
5-13-2016 Insider Buy	Howard B. Rosen CEO	$3.26 CAGR »	$33,271.56 10,206 shares
5-12-2016 Insider Buy	Mark G. Edwards Director	$3.15 CAGR »	$47,250.00 15,000 shares
5-7-2015 Insider Buy	Mark G. Edwards Director	$3.13 CAGR »	$125,116.00 40,000 shares
6-23-2014 Insider Buy	Richard Afable Director	$10.30 CAGR »	$10,300.00 1,000 shares
11-7-2013 Insider Buy	PERCEPTIVE ADVISORS LLC >10% Owner	$6.51 CAGR »	$1,301,470.00 200,000 shares
11-4-2013 Insider Buy	PERCEPTIVE ADVISORS LLC >10% Owner	$6.87 CAGR »	$1,064,292.00 155,000 shares
11-1-2013 Insider Buy	PERCEPTIVE ADVISORS LLC >10% Owner	$6.91 CAGR »	$2,490,540.07 360,660 shares
7-23-2013 Insider Buy	PERCEPTIVE ADVISORS LLC >10% Owner	$11.65 CAGR »	$9,902,500.00 850,000 shares
6-6-2013 Insider Buy	Mark G. Edwards Director	$8.10 CAGR »	$81,000.00 10,000 shares
12-7-2012 Insider Buy	Mark A. Wan Director and >10% Owner	$3.31 CAGR »	$7,999,998.58 2,416,918 shares
5-29-2012 Insider Buy	Mark A. Wan Director and >10% Owner	$3.40 CAGR »	$967,973.20 284,698 shares
5-29-2012 Insider Buy	Venture Partners Qualified Purchaser Fund L. P. Skyline IV Director and >10% Owner	$3.40 CAGR »	$967,973.20 284,698 shares
12-1-2011 Insider Buy	Mark G. Edwards Director	$2.79 CAGR »	$27,900.00 10,000 shares

Also See: Institutional Holders of ACRX
Also See: SEC filings

Below we present the annualized performance delivered by ACRX stock since 12-13-2023 (the date of the most recent insider purchase). The performance of the investment from the time ACRX insider buying occurred is the ultimate test of whether insiders were right about ACRX being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	12/14/2023
End date:	01/09/2024
Start price/share:	$0.74
End price/share:	$0.86
Dividends collected/share:	$0.00
Total return:	16.22%
Annualized Gain:	227.65%
Starting investment:	$10,000.00
Ending investment:	$11,622.00
Years:	0.07

ACRX Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ACRX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding ACRX

ACRX — Current Quote

Quotes delayed 20 minutes

Free ACRX Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

ACRX — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the ACRX Insider Buying occurred are:

SBH Insider Buying
ARIS Insider Buying
CARS Insider Buying
SNAX Insider Buying
PFL Insider Buying
CLRO Insider Buying
CTCX Insider Buying
LUXH Insider Buying
NODK Insider Buying
QRHC Insider Buying

ACRX Insider Buying

ACRX Insider Buying | www.HoldingsChannel.com